Leslie R. Schover, professor of behavioral science, The University of Texas MD Anderson Cancer Center, discusses information and education for patients regarding sexuality after treatment.
Irene Hutchins, M.D., and her patient Steve Valentine, both accomplished ballroom dancers, made a pact to dance together once he had recovered from late-stage Burkitt lymphoma. They performed their victory dance June 11 during Cancer Survivors Day at Scripps Green Hospital, in La Jolla, California, where Hutchins treated Valentine.
Young adult survivor Molly McMaster turns her experience into a national tour and non-profit group dedicated to raising awareness on colon cancer.
An essay honoring SARA SARGENTE, RN, OCN [ORANGE REGIONAL MEDICAL CENTER, MIDDLETOWN, NEW YORK]
When I returned home from my first visit to my surgeon after my diagnosis of breast cancer, I could see the look of worry on my mother's face.
SLEEPING SOUNDLY, 5-year-old Malia moved slowly in her bed, teddy and blanket close to her side.
Clinical trials can provide patients with early access to promising cancer immunotherapies.
Patients with treatment-naive CLL/SLL experienced long-term improved efficacy when treated with Brukinsa compared with bendamustine plus Rituxan.
City of Hope sets the bar for treating people, not just diseases.
A thoughtless birthday mammogram reminder underscored how the healthcare system ignored my reality of living with metastatic breast cancer.
Oncology nurses tend to the needs of patients with cancer with great care, but they also tend to the unspoken needs of their patients.
Dr. Valerie Lee discussed emerging targeted therapies and personalized medicine approaches that are showing promise for those with gastrointestinal cancer.
When people tell me I have metastatic cancer, I don't let their doom and gloom stop me — I'm going to bloom like a flower.
The discussion will wrap up with perspectives on the future of CLL treatment, including anticipated improvements in patient care and quality of life, emerging therapies, and evolving patient roles in care decisions.
One person describes an oncology nurse practitioner as one to give practical advice and guidance for everyone she encounters.
For over 20 years, Dr. Brian Berryman has been a tireless advocate and compassionate care provider for those affected by multiple myeloma.
Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, and Sara A. Hurvitz, M.D., discuss treatment approaches and modifications during the COVID-19 pandemic.
Marie Riehl's willingness to step outside of her professional comfort zone has allowed her to be an extraordinary patient advocate.
Patients with myelofibrosis should reflect on their personal priorities and quality of life goals, understand the range of available JAK inhibitor treatment options, and openly communicate with their doctor to arrive at a shared decision for managing their disease.
During a chemotherapy session for colon cancer, I wrote two poems about my take on cancer.
Because the five-year relative survival rate for people with esophageal cancer is approximately 22%, this makes early detection of the essence.
Now having conquered three cancers and am fighting metastatic pancreatic cancer, scars from all the surgeries within the last 26 years have shown victories and hope.
Dr. Roman Perez-Soler received his original training in Spain but has been a constant beloved presence in the U.S. lung cancer arena for more than 30 years.
I share how I survived multiple myeloma, painful spine fractures and years of recovery to reclaim my independence and vitality.
A patient undergoing treatment for neuroendocrine tumors maintained a positive attitude about his cancer through phone calls from his care manager to check in after appointments, among other efforts.